{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T14:00:00Z","timestamp":1792936800008,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A2C3006699"],"award-info":[{"award-number":["NRF-2020R1A2C3006699"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    New therapeutic targets, especially those that stimulate bone formation in cortical bone, are needed to overcome the limitations of current antiosteoporotic drugs. We previously demonstrated that factors secreted from megakaryocytes (MKs) promote bone formation. Here we conducted a proteomic analysis to identify a novel bone-forming factor from MK secretions. We revealed that\n                    <jats:italic>Vgf<\/jats:italic>\n                    , a nerve growth factor-responsive gene, and its derived active peptide AQEE30 in MK-conditioned medium play important roles in osteoblast proliferation and in vitro bone formation. In both\n                    <jats:italic>Vgf<\/jats:italic>\n                    -deficient male and female mice, the cortical bone mass was significantly decreased due to reductions in osteoblast number and bone formation activity. AQEE30 stimulated intracellular cyclic adenosine monophosphate (cAMP) levels and protein kinase A (PKA) activity in osteoblasts, whereas an adenylyl cyclase inhibitor blocked AQEE30-stimulated osteoblast proliferation and in vitro bone formation. Complement C3a receptor-1 (C3AR1) was expressed and interacted with AQEE30 in osteoblasts, and C3AR1 inhibition blocked all AQEE30-induced changes, including stimulated proliferation, bone formation and cAMP production, in osteoblasts. Injecting mini-PEGylated AQEE30 into calvaria increased the number of osteocalcin-positive cells and new bone formation. In conclusion, this study reveals a novel role of VGF in bone formation, particularly in cortical bone, and shows that AQEE30, a VGF-derived peptide, mediates this role by activating cAMP\u2013PKA signaling via the C3AR1 receptor in osteoblasts.\n                  <\/jats:p>","DOI":"10.1038\/s12276-025-01419-y","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:04:19Z","timestamp":1741838659000},"page":"637-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["VGF and the VGF-derived peptide AQEE30 stimulate osteoblastic bone formation through the C3a receptor"],"prefix":"10.1038","volume":"57","author":[{"given":"Sung-Ah","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hyuk","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayea","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-1806","authenticated-orcid":false,"given":"Xiangguo","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-7208","authenticated-orcid":false,"given":"In-Jeoung","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0496-247X","authenticated-orcid":false,"given":"Seung Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-8842","authenticated-orcid":false,"given":"Je-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-3677","authenticated-orcid":false,"given":"Jung-Min","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"1419_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy.","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285, 785\u2013795 (2001).","journal-title":"JAMA"},{"key":"1419_CR2","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/TCRM.S138000","volume":"14","author":"F Pouresmaeili","year":"2018","unstructured":"Pouresmaeili, F., Kamalidehghan, B., Kamarehei, M. & Goh, Y. M. A comprehensive overview on osteoporosis and its risk factors. Ther. Clin. Risk Manag. 14, 2029\u20132049 (2018).","journal-title":"Ther. Clin. Risk Manag."},{"key":"1419_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi, M. Skeletal remodeling in health and disease. Nat. Med. 13, 791\u2013801 (2007).","journal-title":"Nat. Med."},{"key":"1419_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/dvg.23490","volume":"60","author":"M Omi","year":"2022","unstructured":"Omi, M. & Mishina, Y. Roles of osteoclasts in alveolar bone remodeling. Genesis 60, e23490 (2022).","journal-title":"Genesis"},{"key":"1419_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fmed.2017.00234","volume":"4","author":"H Bi","year":"2017","unstructured":"Bi, H. et al. Key triggers of osteoclast-related diseases and available strategies for targeted therapies: a review. Front. Med. 4, 234 (2017).","journal-title":"Front. Med."},{"key":"1419_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1210\/js.2018-00118","volume":"2","author":"AV Haas","year":"2018","unstructured":"Haas, A. V. & LeBoff, M. S. Osteoanabolic agents for osteoporosis. J. Endocr. Soc. 2, 922\u2013932 (2018).","journal-title":"J. Endocr. Soc."},{"key":"1419_CR7","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina, C. V. et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J. Clin. Endocrinol. Metab. 90, 1294\u20131301 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1419_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis, E., Giustina, A. & Bilezikian, J. P. Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 357, 905\u2013916 (2007).","journal-title":"N. Engl. J. Med."},{"key":"1419_CR9","doi-asserted-by":"crossref","unstructured":"Rauner, M., Taipaleenmaki, H., Tsourdi, E. & Winter E. M. Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application. J. Clin. Med. 10, 787 (2021).","DOI":"10.3390\/jcm10040787"},{"key":"1419_CR10","first-page":"801","volume":"34","author":"BC Silva","year":"2011","unstructured":"Silva, B. C., Costa, A. G., Cusano, N. E., Kousteni, S. & Bilezikian, J. P. Catabolic and anabolic actions of parathyroid hormone on the skeleton. J. Endocrinol. Invest. 34, 801\u2013810 (2011).","journal-title":"J. Endocrinol. Invest."},{"key":"1419_CR11","doi-asserted-by":"crossref","unstructured":"Witcher, P. C. et al. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition. JCI Insight 3, 1172 (2018).","DOI":"10.1172\/jci.insight.98673"},{"key":"1419_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/joim.12873","volume":"285","author":"M Lorentzon","year":"2019","unstructured":"Lorentzon, M. Treating osteoporosis to prevent fractures: current concepts and future developments. J. Intern. Med. 285, 381\u2013394 (2019).","journal-title":"J. Intern. Med."},{"key":"1419_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59250-6","volume":"10","author":"YS Lee","year":"2020","unstructured":"Lee, Y. S. et al. Regulation of bone metabolism by megakaryocytes in a paracrine manner. Sci. Rep. 10, 2277 (2020).","journal-title":"Sci. Rep."},{"key":"1419_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/frne.2000.0199","volume":"21","author":"SR Salton","year":"2000","unstructured":"Salton, S. R. et al. VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance. Front. Neuroendocrinol. 21, 199\u2013219 (2000).","journal-title":"Front. Neuroendocrinol."},{"key":"1419_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1023\/B:CEMN.0000023627.79947.22","volume":"24","author":"A Levi","year":"2004","unstructured":"Levi, A., Ferri, G. L., Watson, E., Possenti, R. & Salton, S. R. Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor. Cell Mol. Neurobiol. 24, 517\u2013533 (2004).","journal-title":"Cell Mol. Neurobiol."},{"key":"1419_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1046\/j.1471-4159.2002.00842.x","volume":"81","author":"E Trani","year":"2002","unstructured":"Trani, E. et al. Isolation and characterization of VGF peptides in rat brain. Role of PC1\/3 and PC2 in the maturation of VGF precursor. J. Neurochem. 81, 565\u2013574 (2002).","journal-title":"J. Neurochem."},{"key":"1419_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-61779-307-3_14","volume":"788","author":"H Schulze","year":"2012","unstructured":"Schulze, H. Culture of murine megakaryocytes and platelets from fetal liver and bone marrow. Methods Mol. Biol. 788, 193\u2013203 (2012).","journal-title":"Methods Mol. Biol."},{"key":"1419_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nbt.2477","volume":"31","author":"YH Sung","year":"2013","unstructured":"Sung, Y. H. et al. Knockout mice created by TALEN-mediated gene targeting. Nat. Biotechnol. 31, 23\u201324 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1419_CR19","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1172\/JCI0215681","volume":"109","author":"X Zhang","year":"2002","unstructured":"Zhang, X. et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109, 1405\u20131415 (2002).","journal-title":"J. Clin. Invest."},{"key":"1419_CR20","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI91086","volume":"128","author":"BJ Kim","year":"2018","unstructured":"Kim, B. J. et al. Osteoclast-secreted SLIT3 coordinates bone resorption and formation. J. Clin. Invest. 128, 1429\u20131441 (2018).","journal-title":"J. Clin. Invest."},{"key":"1419_CR21","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1074\/jbc.M114.603977","volume":"290","author":"JP Belman","year":"2015","unstructured":"Belman, J. P. et al. Acetylation of TUG protein promotes the accumulation of GLUT4 glucose transporters in an insulin-responsive intracellular compartment. J. Biol. Chem. 290, 4447\u20134463 (2015).","journal-title":"J. Biol. Chem."},{"key":"1419_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fendo.2015.00003","volume":"6","author":"JE Lewis","year":"2015","unstructured":"Lewis, J. E., Brameld, J. M. & Jethwa, P. H. Neuroendocrine role for VGF. Front. Endocrinol. 6, 3 (2015).","journal-title":"Front. Endocrinol."},{"key":"1419_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.devcel.2006.03.004","volume":"10","author":"C Berthet","year":"2006","unstructured":"Berthet, C. et al. Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation. Dev. Cell 10, 563\u2013573 (2006).","journal-title":"Dev. Cell"},{"key":"1419_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mce.2015.12.014","volume":"432","author":"N Bonnet","year":"2016","unstructured":"Bonnet, N., Garnero, P. & Ferrari, S. Periostin action in bone. Mol. Cell Endocrinol. 432, 75\u201382 (2016).","journal-title":"Mol. Cell Endocrinol."},{"key":"1419_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00441-012-1546-x","volume":"352","author":"T Komori","year":"2013","unstructured":"Komori, T. Functions of the osteocyte network in the regulation of bone mass. Cell Tissue Res. 352, 191\u2013198 (2013).","journal-title":"Cell Tissue Res."},{"key":"1419_CR26","doi-asserted-by":"crossref","unstructured":"Komori, T. Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int. J. Mol. Sci. 20, 1694 (2019).","DOI":"10.3390\/ijms20071694"},{"key":"1419_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biocel.2016.05.015","volume":"77","author":"P Duan","year":"2016","unstructured":"Duan, P. & Bonewald, L. F. The role of the Wnt\/beta-catenin signaling pathway in formation and maintenance of bone and teeth. Int. J. Biochem. Cell Biol. 77, 23\u201329 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1419_CR28","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1073\/pnas.0711190105","volume":"105","author":"R Siddappa","year":"2008","unstructured":"Siddappa, R. et al. cAMP\/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc. Natl Acad. Sci. USA 105, 7281\u20137286 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1419_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas, T. & Dutta, A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9, 400\u2013414 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1419_CR30","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","volume":"25","author":"C Giacinti","year":"2006","unstructured":"Giacinti, C. & Giordano, A. RB and cell cycle progression. Oncogene 25, 5220\u20135227 (2006).","journal-title":"Oncogene"},{"key":"1419_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang, H., Kong, Q., Wang, J., Jiang, Y. & Hua, H. Complex roles of cAMP\u2013PKA\u2013CREB signaling in cancer. Exp. Hematol. Oncol. 9, 32 (2020).","journal-title":"Exp. Hematol. Oncol."},{"key":"1419_CR32","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.str.2014.10.001","volume":"22","author":"C Cero","year":"2014","unstructured":"Cero, C. et al. The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism. Structure 22, 1744\u20131753 (2014).","journal-title":"Structure"},{"key":"1419_CR33","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4049\/jimmunol.1700318","volume":"199","author":"KM Quell","year":"2017","unstructured":"Quell, K. M. et al. Monitoring C3aR expression using a floxed tdTomato-C3aR reporter knock-in mouse. J. Immunol. 199, 688\u2013706 (2017).","journal-title":"J. Immunol."},{"key":"1419_CR34","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1182\/blood-2008-05-156646","volume":"112","author":"K Li","year":"2008","unstructured":"Li, K. et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112, 5084\u20135094 (2008).","journal-title":"Blood"},{"key":"1419_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0168-3659(90)90127-F","volume":"11","author":"F Fuertges","year":"1990","unstructured":"Fuertges, F. & Abuchowski, A. The clinical efficacy of poly(ethylene glycol)-modified proteins. J. Control. Release 11, 139\u2013148 (1990).","journal-title":"J. Control. Release"},{"key":"1419_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jddst.2018.09.009","volume":"49","author":"G Peng","year":"2019","unstructured":"Peng, G., Pan, X., Hu, H., Xu, Y. & Wu, C. N-terminal site-specific PEGylation enhances the circulation half-life of thymosin alpha 1. J. Drug Deliv. Sci. Technol. 49, 405\u2013415 (2019).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"1419_CR37","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/nm1669","volume":"13","author":"JG Hunsberger","year":"2007","unstructured":"Hunsberger, J. G. et al. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 13, 1476\u20131482 (2007).","journal-title":"Nat. Med."},{"key":"1419_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34585-3","volume":"8","author":"H Takeuchi","year":"2018","unstructured":"Takeuchi, H. et al. VGF nerve growth factor inducible is involved in retinal ganglion cells death induced by optic nerve crush. Sci. Rep. 8, 16443 (2018).","journal-title":"Sci. Rep."},{"key":"1419_CR39","doi-asserted-by":"publisher","first-page":"15388","DOI":"10.1523\/JNEUROSCI.0293-12.2012","volume":"32","author":"H Sato","year":"2012","unstructured":"Sato, H. et al. Thalamus-derived molecules promote survival and dendritic growth of developing cortical neurons. J. Neurosci. 32, 15388\u201315402 (2012).","journal-title":"J. Neurosci."},{"key":"1419_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.140","volume":"3","author":"Y Noda","year":"2015","unstructured":"Noda, Y. et al. VGF and striatal cell damage in in vitro and in vivo models of Huntington\u2019s disease. Pharmacol. Res. Perspect. 3, e00140 (2015).","journal-title":"Pharmacol. Res. Perspect."},{"key":"1419_CR41","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1523\/JNEUROSCI.22-16-06929.2002","volume":"22","author":"S Hahm","year":"2002","unstructured":"Hahm, S. et al. VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting. J. Neurosci. 22, 6929\u20136938 (2002).","journal-title":"J. Neurosci."},{"key":"1419_CR42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0896-6273(00)80806-5","volume":"23","author":"S Hahm","year":"1999","unstructured":"Hahm, S. et al. Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 23, 537\u2013548 (1999).","journal-title":"Neuron"},{"key":"1419_CR43","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1523\/JNEUROSCI.0584-15.2015","volume":"35","author":"WJ Lin","year":"2015","unstructured":"Lin, W. J. et al. VGF and its C-terminal peptide TLQP-62 regulate memory formation in hippocampus via a BDNF-TrkB-dependent mechanism. J. Neurosci. 35, 10343\u201310356 (2015).","journal-title":"J. Neurosci."},{"key":"1419_CR44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1471-4159.2007.05068.x","volume":"104","author":"C Severini","year":"2008","unstructured":"Severini, C. et al. TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation. J. Neurochem. 104, 534\u2013544 (2008).","journal-title":"J. Neurochem."},{"key":"1419_CR45","doi-asserted-by":"publisher","first-page":"14584","DOI":"10.1073\/pnas.0606102103","volume":"103","author":"A Bartolomucci","year":"2006","unstructured":"Bartolomucci, A. et al. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc. Natl Acad. Sci. USA 103, 14584\u201314589 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1419_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00198-006-0296-6","volume":"18","author":"E Seeman","year":"2007","unstructured":"Seeman, E. The periosteum\u2014a surface for all seasons. Osteoporos. Int. 18, 123\u2013128 (2007).","journal-title":"Osteoporos. Int."},{"key":"1419_CR47","doi-asserted-by":"crossref","unstructured":"Xing, W., Pourteymoor, S., Kesavan, C., Gomez, G. A. & Mohan, S. Mice with targeted knockout of tetraspanin 3 exhibit reduced trabecular bone mass caused by decreased osteoblast functions. Cells 11, 977 (2022).","DOI":"10.3390\/cells11060977"},{"key":"1419_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep25964","volume":"6","author":"G Jadhav","year":"2016","unstructured":"Jadhav, G., Teguh, D., Kenny, J., Tickner, J. & Xu, J. Morc3 mutant mice exhibit reduced cortical area and thickness, accompanied by altered haematopoietic stem cells niche and bone cell differentiation. Sci. Rep. 6, 25964 (2016).","journal-title":"Sci. Rep."},{"key":"1419_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/jmcb\/mjz028","volume":"12","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. PIP5k1beta controls bone homeostasis through modulating both osteoclast and osteoblast differentiation. J. Mol. Cell Biol. 12, 55\u201370 (2020).","journal-title":"J. Mol. Cell Biol."},{"key":"1419_CR50","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/jbm.a.34026","volume":"100","author":"X Wang","year":"2012","unstructured":"Wang, X., Heath, D. E. & Cooper, S. L. Endothelial cell adhesion and proliferation to PEGylated polymers with covalently linked RGD peptides. J. Biomed. Mater. Res. A 100, 794\u2013801 (2012).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"1419_CR51","doi-asserted-by":"crossref","unstructured":"Piotrowski, P., Klimek, K., Ginalska, G. & Kaim, A. Beneficial influence of water-soluble PEG-functionalized C(60) fullerene on human osteoblast growth in vitro. Materials 14, 1566 (2021).","DOI":"10.3390\/ma14061566"},{"key":"1419_CR52","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1074\/jbc.273.13.7547","volume":"273","author":"Y Tintut","year":"1998","unstructured":"Tintut, Y., Parhami, F., Bostrom, K., Jackson, S. M. & Demer, L. L. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. J. Biol. Chem. 273, 7547\u20137553 (1998).","journal-title":"J. Biol. Chem."},{"key":"1419_CR53","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/jbmr.2187","volume":"29","author":"K Matsuoka","year":"2014","unstructured":"Matsuoka, K., Park, K. A., Ito, M., Ikeda, K. & Takeshita, S. Osteoclast-derived complement component 3a stimulates osteoblast differentiation. J. Bone Miner. Res. 29, 1522\u20131530 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"1419_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2012.05.011","volume":"16","author":"SB Stephens","year":"2012","unstructured":"Stephens, S. B. et al. A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet beta-cell survival and function. Cell Metab. 16, 33\u201343 (2012).","journal-title":"Cell Metab."},{"key":"1419_CR55","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1476-5381.2009.00192.x","volume":"157","author":"C Severini","year":"2009","unstructured":"Severini, C. et al. In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions. Br. J. Pharmacol. 157, 984\u2013993 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"1419_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.bbr.2012.01.038","volume":"229","author":"M Razzoli","year":"2012","unstructured":"Razzoli, M. et al. Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses. Behav. Brain Res. 229, 333\u2013339 (2012).","journal-title":"Behav. Brain Res."},{"key":"1419_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1042\/BJ20111165","volume":"441","author":"R Possenti","year":"2012","unstructured":"Possenti, R. et al. Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21. Biochem. J. 441, 511\u2013522 (2012).","journal-title":"Biochem. J."},{"key":"1419_CR58","doi-asserted-by":"publisher","first-page":"27434","DOI":"10.1074\/jbc.M113.497214","volume":"288","author":"S Hannedouche","year":"2013","unstructured":"Hannedouche, S. et al. Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells. J. Biol. Chem. 288, 27434\u201327443 (2013).","journal-title":"J. Biol. Chem."},{"key":"1419_CR59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.molmet.2016.10.005","volume":"6","author":"C Cero","year":"2017","unstructured":"Cero, C. et al. The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis. Mol. Metab. 6, 148\u2013158 (2017).","journal-title":"Mol. Metab."},{"key":"1419_CR60","doi-asserted-by":"publisher","first-page":"e0185176","DOI":"10.1371\/journal.pone.0185176","volume":"12","author":"S Akhter","year":"2017","unstructured":"Akhter, S. et al. The human VGF-derived bioactive peptide TLQP-21 binds heat shock 71 kDa protein 8 (HSPA8)on the surface of SH-SY5Y cells. PLoS ONE 12, e0185176 (2017).","journal-title":"PLoS ONE"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01419-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01419-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01419-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:05:26Z","timestamp":1743725126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01419-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01419-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4285593\/v1","asserted-by":"object"}]},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"One patent has been filed for this invention, application number KR2021\/0000275, by J.-M. Koh. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}